The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Transdermal Drug Delivery System-Global Market Insights and Sales Trends 2025
Synopsis
Transdermal Drug Delivery System is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. Often, this promotes healing to an injured area of the body. An advantage of a transdermal drug delivery route over other types of medication delivery such as oral, topical, intravenous, intramuscular, etc. is that the patch provides a controlled release of the medication into the patient, usually through either a porous membrane covering a reservoir of medication or through body heat melting thin layers of medication embedded in the adhesive.
The global Transdermal Drug Delivery System market size is expected to reach US$ 36450 million by 2029, growing at a CAGR of 13.3% from 2023 to 2029. The market is mainly driven by the significant applications of Transdermal Drug Delivery System in various end use industries. The expanding demands from the OTC and Rx, are propelling Transdermal Drug Delivery System market. Fentanyl, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Nitroglycerin segment is estimated at % CAGR for the next seven-year period.
Global Transdermal Drug Delivery System key players include Hisamitsu, Mylan, GSK, Novartis, Teve (Actavis), etc. Global top five manufacturers hold a share over 65%. North America is the largest market, with a share over 40%, followed by Europe and Asia-Pacific, both have a share over 45% percent.
In terms of product, Nitroglycerin is the largest segment, with a share over 25%. And in terms of application, the largest application is OTC, followed by RX.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Transdermal Drug Delivery System, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Transdermal Drug Delivery System market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Transdermal Drug Delivery System market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Transdermal Drug Delivery System sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Transdermal Drug Delivery System covered in this report include Hisamitsu, Mylan, GSK, Novartis, Teve (Actavis), Johnson & Johnson, Lohmann, Teikoku Seiyaku and Bayer, etc.
The global Transdermal Drug Delivery System market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Hisamitsu
Mylan
GSK
Novartis
Teve (Actavis)
Johnson & Johnson
Lohmann
Teikoku Seiyaku
Bayer
Lingrui
Sanofi
Qizheng
Endo
Huarun 999
Haw Par
Nichiban
Mentholatum
Laboratoires Genevrier
Global Transdermal Drug Delivery System market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Transdermal Drug Delivery System market, Segment by Type:
Fentanyl
Nitroglycerin
Estradiol
Nicotine
Other
Global Transdermal Drug Delivery System market, by Application
OTC
Rx
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Transdermal Drug Delivery System companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Transdermal Drug Delivery System is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. Often, this promotes healing to an injured area of the body. An advantage of a transdermal drug delivery route over other types of medication delivery such as oral, topical, intravenous, intramuscular, etc. is that the patch provides a controlled release of the medication into the patient, usually through either a porous membrane covering a reservoir of medication or through body heat melting thin layers of medication embedded in the adhesive.
The global Transdermal Drug Delivery System market size is expected to reach US$ 36450 million by 2029, growing at a CAGR of 13.3% from 2023 to 2029. The market is mainly driven by the significant applications of Transdermal Drug Delivery System in various end use industries. The expanding demands from the OTC and Rx, are propelling Transdermal Drug Delivery System market. Fentanyl, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Nitroglycerin segment is estimated at % CAGR for the next seven-year period.
Global Transdermal Drug Delivery System key players include Hisamitsu, Mylan, GSK, Novartis, Teve (Actavis), etc. Global top five manufacturers hold a share over 65%. North America is the largest market, with a share over 40%, followed by Europe and Asia-Pacific, both have a share over 45% percent.
In terms of product, Nitroglycerin is the largest segment, with a share over 25%. And in terms of application, the largest application is OTC, followed by RX.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Transdermal Drug Delivery System, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Transdermal Drug Delivery System market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Transdermal Drug Delivery System market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Transdermal Drug Delivery System sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Transdermal Drug Delivery System covered in this report include Hisamitsu, Mylan, GSK, Novartis, Teve (Actavis), Johnson & Johnson, Lohmann, Teikoku Seiyaku and Bayer, etc.
The global Transdermal Drug Delivery System market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Hisamitsu
Mylan
GSK
Novartis
Teve (Actavis)
Johnson & Johnson
Lohmann
Teikoku Seiyaku
Bayer
Lingrui
Sanofi
Qizheng
Endo
Huarun 999
Haw Par
Nichiban
Mentholatum
Laboratoires Genevrier
Global Transdermal Drug Delivery System market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Transdermal Drug Delivery System market, Segment by Type:
Fentanyl
Nitroglycerin
Estradiol
Nicotine
Other
Global Transdermal Drug Delivery System market, by Application
OTC
Rx
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Transdermal Drug Delivery System companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Transdermal Drug Delivery System
1.1 Transdermal Drug Delivery System Market Overview
1.1.1 Transdermal Drug Delivery System Product Scope
1.1.2 Transdermal Drug Delivery System Market Status and Outlook
1.2 Global Transdermal Drug Delivery System Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Transdermal Drug Delivery System Market Size by Region (2018-2029)
1.4 Global Transdermal Drug Delivery System Historic Market Size by Region (2018-2023)
1.5 Global Transdermal Drug Delivery System Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Transdermal Drug Delivery System Market Size (2018-2029)
1.6.1 North America Transdermal Drug Delivery System Market Size (2018-2029)
1.6.2 Europe Transdermal Drug Delivery System Market Size (2018-2029)
1.6.3 Asia-Pacific Transdermal Drug Delivery System Market Size (2018-2029)
1.6.4 Latin America Transdermal Drug Delivery System Market Size (2018-2029)
1.6.5 Middle East & Africa Transdermal Drug Delivery System Market Size (2018-2029)
2 Transdermal Drug Delivery System Market by Type
2.1 Introduction
2.1.1 Fentanyl
2.1.2 Nitroglycerin
2.1.3 Estradiol
2.1.4 Nicotine
2.1.5 Other
2.2 Global Transdermal Drug Delivery System Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Transdermal Drug Delivery System Historic Market Size by Type (2018-2023)
2.2.2 Global Transdermal Drug Delivery System Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Transdermal Drug Delivery System Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Transdermal Drug Delivery System Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Transdermal Drug Delivery System Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Transdermal Drug Delivery System Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Transdermal Drug Delivery System Revenue Breakdown by Type (2018-2029)
3 Transdermal Drug Delivery System Market Overview by Application
3.1 Introduction
3.1.1 OTC
3.1.2 Rx
3.2 Global Transdermal Drug Delivery System Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Transdermal Drug Delivery System Historic Market Size by Application (2018-2023)
3.2.2 Global Transdermal Drug Delivery System Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Transdermal Drug Delivery System Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Transdermal Drug Delivery System Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Transdermal Drug Delivery System Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Transdermal Drug Delivery System Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Transdermal Drug Delivery System Revenue Breakdown by Application (2018-2029)
4 Transdermal Drug Delivery System Competition Analysis by Players
4.1 Global Transdermal Drug Delivery System Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Transdermal Drug Delivery System as of 2022)
4.3 Date of Key Players Enter into Transdermal Drug Delivery System Market
4.4 Global Top Players Transdermal Drug Delivery System Headquarters and Area Served
4.5 Key Players Transdermal Drug Delivery System Product Solution and Service
4.6 Competitive Status
4.6.1 Transdermal Drug Delivery System Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Hisamitsu
5.1.1 Hisamitsu Profile
5.1.2 Hisamitsu Main Business
5.1.3 Hisamitsu Transdermal Drug Delivery System Products, Services and Solutions
5.1.4 Hisamitsu Transdermal Drug Delivery System Revenue (US$ Million) & (2018-2023)
5.1.5 Hisamitsu Recent Developments
5.2 Mylan
5.2.1 Mylan Profile
5.2.2 Mylan Main Business
5.2.3 Mylan Transdermal Drug Delivery System Products, Services and Solutions
5.2.4 Mylan Transdermal Drug Delivery System Revenue (US$ Million) & (2018-2023)
5.2.5 Mylan Recent Developments
5.3 GSK
5.3.1 GSK Profile
5.3.2 GSK Main Business
5.3.3 GSK Transdermal Drug Delivery System Products, Services and Solutions
5.3.4 GSK Transdermal Drug Delivery System Revenue (US$ Million) & (2018-2023)
5.3.5 Novartis Recent Developments
5.4 Novartis
5.4.1 Novartis Profile
5.4.2 Novartis Main Business
5.4.3 Novartis Transdermal Drug Delivery System Products, Services and Solutions
5.4.4 Novartis Transdermal Drug Delivery System Revenue (US$ Million) & (2018-2023)
5.4.5 Novartis Recent Developments
5.5 Teve (Actavis)
5.5.1 Teve (Actavis) Profile
5.5.2 Teve (Actavis) Main Business
5.5.3 Teve (Actavis) Transdermal Drug Delivery System Products, Services and Solutions
5.5.4 Teve (Actavis) Transdermal Drug Delivery System Revenue (US$ Million) & (2018-2023)
5.5.5 Teve (Actavis) Recent Developments
5.6 Johnson & Johnson
5.6.1 Johnson & Johnson Profile
5.6.2 Johnson & Johnson Main Business
5.6.3 Johnson & Johnson Transdermal Drug Delivery System Products, Services and Solutions
5.6.4 Johnson & Johnson Transdermal Drug Delivery System Revenue (US$ Million) & (2018-2023)
5.6.5 Johnson & Johnson Recent Developments
5.7 Lohmann
5.7.1 Lohmann Profile
5.7.2 Lohmann Main Business
5.7.3 Lohmann Transdermal Drug Delivery System Products, Services and Solutions
5.7.4 Lohmann Transdermal Drug Delivery System Revenue (US$ Million) & (2018-2023)
5.7.5 Lohmann Recent Developments
5.8 Teikoku Seiyaku
5.8.1 Teikoku Seiyaku Profile
5.8.2 Teikoku Seiyaku Main Business
5.8.3 Teikoku Seiyaku Transdermal Drug Delivery System Products, Services and Solutions
5.8.4 Teikoku Seiyaku Transdermal Drug Delivery System Revenue (US$ Million) & (2018-2023)
5.8.5 Teikoku Seiyaku Recent Developments
5.9 Bayer
5.9.1 Bayer Profile
5.9.2 Bayer Main Business
5.9.3 Bayer Transdermal Drug Delivery System Products, Services and Solutions
5.9.4 Bayer Transdermal Drug Delivery System Revenue (US$ Million) & (2018-2023)
5.9.5 Bayer Recent Developments
5.10 Lingrui
5.10.1 Lingrui Profile
5.10.2 Lingrui Main Business
5.10.3 Lingrui Transdermal Drug Delivery System Products, Services and Solutions
5.10.4 Lingrui Transdermal Drug Delivery System Revenue (US$ Million) & (2018-2023)
5.10.5 Lingrui Recent Developments
5.11 Sanofi
5.11.1 Sanofi Profile
5.11.2 Sanofi Main Business
5.11.3 Sanofi Transdermal Drug Delivery System Products, Services and Solutions
5.11.4 Sanofi Transdermal Drug Delivery System Revenue (US$ Million) & (2018-2023)
5.11.5 Sanofi Recent Developments
5.12 Qizheng
5.12.1 Qizheng Profile
5.12.2 Qizheng Main Business
5.12.3 Qizheng Transdermal Drug Delivery System Products, Services and Solutions
5.12.4 Qizheng Transdermal Drug Delivery System Revenue (US$ Million) & (2018-2023)
5.12.5 Qizheng Recent Developments
5.13 Endo
5.13.1 Endo Profile
5.13.2 Endo Main Business
5.13.3 Endo Transdermal Drug Delivery System Products, Services and Solutions
5.13.4 Endo Transdermal Drug Delivery System Revenue (US$ Million) & (2018-2023)
5.13.5 Endo Recent Developments
5.14 Huarun 999
5.14.1 Huarun 999 Profile
5.14.2 Huarun 999 Main Business
5.14.3 Huarun 999 Transdermal Drug Delivery System Products, Services and Solutions
5.14.4 Huarun 999 Transdermal Drug Delivery System Revenue (US$ Million) & (2018-2023)
5.14.5 Huarun 999 Recent Developments
5.15 Haw Par
5.15.1 Haw Par Profile
5.15.2 Haw Par Main Business
5.15.3 Haw Par Transdermal Drug Delivery System Products, Services and Solutions
5.15.4 Haw Par Transdermal Drug Delivery System Revenue (US$ Million) & (2018-2023)
5.15.5 Haw Par Recent Developments
5.16 Nichiban
5.16.1 Nichiban Profile
5.16.2 Nichiban Main Business
5.16.3 Nichiban Transdermal Drug Delivery System Products, Services and Solutions
5.16.4 Nichiban Transdermal Drug Delivery System Revenue (US$ Million) & (2018-2023)
5.16.5 Nichiban Recent Developments
5.17 Mentholatum
5.17.1 Mentholatum Profile
5.17.2 Mentholatum Main Business
5.17.3 Mentholatum Transdermal Drug Delivery System Products, Services and Solutions
5.17.4 Mentholatum Transdermal Drug Delivery System Revenue (US$ Million) & (2018-2023)
5.17.5 Mentholatum Recent Developments
5.18 Laboratoires Genevrier
5.18.1 Laboratoires Genevrier Profile
5.18.2 Laboratoires Genevrier Main Business
5.18.3 Laboratoires Genevrier Transdermal Drug Delivery System Products, Services and Solutions
5.18.4 Laboratoires Genevrier Transdermal Drug Delivery System Revenue (US$ Million) & (2018-2023)
5.18.5 Laboratoires Genevrier Recent Developments
6 North America
6.1 North America Transdermal Drug Delivery System Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Transdermal Drug Delivery System Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Transdermal Drug Delivery System Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Transdermal Drug Delivery System Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Transdermal Drug Delivery System Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Transdermal Drug Delivery System Market Dynamics
11.1 Transdermal Drug Delivery System Industry Trends
11.2 Transdermal Drug Delivery System Market Drivers
11.3 Transdermal Drug Delivery System Market Challenges
11.4 Transdermal Drug Delivery System Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
